New Epinephrine Nasal Spray
Anaphylaxis specialist Jay Lieberman, MD, FAAAAI, tells us everything we need to know about the first FDA approved epinephrine nasal spray to treat type 1 allergic reactions and anaphylaxis. (Participants in this podcast have disclosed a past financial relationship with the drug manufacturer.)
12 Elo 202424min
Contact Dermatitis
Marcella Aquino, MD, FAAAAI, provides an outstanding overview of this common skin condition and also discusses the new AAAAI educational course now available. Access the module.
6 Elo 202444min
AI in A/I: It’s Already Here – Are You Using It?
Nicholas L. Rider, DO, FAAAAI, offers tremendous insight into the risks, benefits and great potential for how artificial intelligence can impact healthcare.
9 Heinä 20241h 4min
Perioperative Anaphylaxis
Gerald Volcheck, MD, FAAAAI, discusses important concepts surrounding anaphylaxis in the operating room as well as the new AAAAI online course that is available now.
19 Kesä 202448min
Striving for the Highest Quality
Kristin Sokol, MD, MS, MPH, FAAAAI, discusses the importance of quality improvement in providing optimal care. Listen now to learn more about AAAAI related initiatives and support tools.
4 Kesä 202438min
Empowering Patients with Food Allergy
Katherine Anagnostou, MD, MSc, PhD, FAAAAI, discusses the evolution and current approaches towards food allergy diagnosis and management. Listen to learn which food allergy advice is now outdated, incorrect and harmful.
13 Touko 202457min
Asthma Awareness Month
Allison Burbank, MD, offers a detailed and extremely insightful conversation surrounding the latest approaches towards asthma management and goals of therapy.
7 Touko 202443min
Elevate Your Practice for a Sustainable Future
Vivian Hernandez-Trujillo, MD, FAAAAI, offers a sneak peek at the exciting 2024 AAAAI Practice Management Workshop taking place July 12-14 in Denver, CO. You won’t want to miss this one!
24 Huhti 202432min
